1.Investigating the clinical and hematological features of chronic myelogenous leukemia at early initial hospitalization
Journal of Practical Medicine 2002;435(11):8-12
From January 1997 to January 1998, there were 21 patients with chronic myelogenous leukemia who admitted to the Clinical Department, National Institute of Hematology and Blood Transfusion, B¹ch Mai Hospital. Mean age of patients was 42.85 for men and 38.12 for women. Among these patients, splenomegaly was observed in 100% of patients. Hyperleukocytosis, hyperthrombocytemia, erythrocytopenia, and hyperuricemia all were measured. 94% of patients were positive with Philadelphia chromosome
Leukemia
;
Hydroxyurea
;
Hematologic Agents
;
diagnosis
2.Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?
Journal of Stroke 2019;21(3):241-241
No abstract available.
Anticoagulants
;
Hematologic Agents
;
Atrial Fibrillation
3.Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease.
Ming-Juan LIU ; Wen-Rong HUANG ; Li YU
Journal of Experimental Hematology 2015;23(2):596-600
Invasive fungal disease (IFD) causes a high morbidity and mortality in patients with hematological malignancies. Reactivation of IFD after chemotherapy or hematopoietic stem cell transplantation (HSCT) is very common and associated with poor prognosis. Secondary antifungal prophylaxis (SAP) is effective in preventing IFD recurrence. With effective SAP, a history of IFD is not an absolute contraindication to allogeneic HSCT or continuation of high-dose chemotherapy. In recent years, a variety of antifungal drugs such as voriconazole, itraconazole, AmB and caspofungin have been found to be effective for SAP. However, its management during granulocytopenia and immunosuppression remains challenging. This review summarizes the current status of SAP in patients with hematological malignancies.
Antifungal Agents
;
Hematologic Neoplasms
;
Humans
;
Immune Tolerance
;
Immunosuppression
;
Mycoses
4.A Case of Paraneoplastic Syndrome Associated with Pancreatic Cancer Presenting as Rheumatoid Arthritis.
Young Il KIM ; Seon Gyu CHOI ; Ho Jun LEE ; Kyung Eun LEE ; Sung Ji LEE ; Seong Rye SEO ; Tae Jong KIM ; Yong Wook PARK ; Shin Seok LEE
Journal of Rheumatic Diseases 2011;18(1):32-35
Paraneoplastic cancer polyarthritis is a very rare manifestation of musculoskeletal disorders associated with several solid and hematologic malignancies. We describe a 71-year-old woman who presented initially with an abrupt onset of rheumatoid arthritis-like symmetrical polyarthritis. The patient was diagnosed with pancreatic cancer with multiple hepatic metastases approximately six months later. Her symptoms of polyarthritis improved after the introduction of medication including non-steroidal anti-inflammatory drugs and disease modifying anti-rheumatic drugs. This case suggests that a hidden malignancy should always be considered in elderly patients, who present with an abrupt onset of symmetric polyarthritis for the first time in their life.
Aged
;
Antirheumatic Agents
;
Arthritis
;
Arthritis, Rheumatoid
;
Female
;
Hematologic Neoplasms
;
Humans
;
Neoplasm Metastasis
;
Pancreatic Neoplasms
;
Paraneoplastic Syndromes
5.Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report.
Jin Geun KIM ; Hye Jeong PARK ; Jung Hyun PARK ; Jiwoong BAEK ; Hyung Jun KIM ; In Ho CHA ; Woong NAM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2013;39(5):246-250
Rhinocerebral mucormycosis (RCM) is an opportunistic, potentially life-threatening fungal disease. This infective disease invades not only the facial sinuses, but also the maxilla, zygoma, and rhino-cerebral structures with a massive destruction of the facial skeletons and soft tissue. This disease progresses within various underlying diseases, such as diabetes mellitus, hematologic malignancy, renal failure, and systemic immunodepression. The relationship between mucormycosis and these underlying conditions have been discussed extensively in the literature. The authors studied 6 cases of RCM diagnosed by a tissue biopsy and treated at the department of oral and maxillofacial surgery, from 1997 to 2012. Patients were treated with several kinds of surgical interventions and antifungal agents, and their clinical & radiological signs, underlying conditions, surgical methods, and outcomes were analyzed.
Antifungal Agents
;
Biopsy
;
Diabetes Mellitus
;
Hematologic Neoplasms
;
Humans
;
Maxilla
;
Mucormycosis*
;
Renal Insufficiency
;
Skeleton
;
Surgery, Oral
;
Zygoma
6.Three Cases of Systemic Candidiasis with Skin Manifestations in Patients with Hematologic Malignancies.
Sun Young LEE ; Sung Eun CHANG ; Jee Ho CHOI ; Kyung Jeh SUNG ; Kee Chan MOON ; Jai Kyoung KOH
Korean Journal of Dermatology 2001;39(4):499-503
Systemic or disseminated candidiasis is a not uncommon serious complication among patients with impaired host-defense mechanisms, particularly among those with hematologic malignancies. Although widespread organ involvement is characteristic of disseminated candidiasis, there is only a few reports of skin manifestation in Korea. The diagnosis is often difficult to establish, since Candida organisms can be cultured from blood specimens in only 25% of the patients. Unless treated, the disease is rapidly fatal. If there is any evidence of respiratory distress or signs of sepsis in hematologic malignancy patients the possibility of systemic candidiasis and the need for parenteral antifungal therapy must be considered by early pathologic diagnosis of heralding skin lesions. We describe three hematologic malignancy patients with systemic candidiasis with disseminated maculopapules and vesicular eruption and respiratory distress. Skin biopsies showed multiple spores and pseudohyphae in the dermis and subcutis. These patients did not respond to intravenous antifungal agents and had fatal course.
Antifungal Agents
;
Biopsy
;
Candida
;
Candidiasis*
;
Dermis
;
Diagnosis
;
Hematologic Neoplasms*
;
Humans
;
Korea
;
Sepsis
;
Skin Manifestations*
;
Skin*
;
Spores
7.Perianal swabs surveillance cultures of Carbapenem-resistant Enterobacteriaceae(CRE) can be hints for CRE bloodstream infection in patients with hematological diseases.
Chun Hui XU ; Yang SU ; Yan Xia LYU ; Zhi Ying TIAN ; Fu Jun SUN ; Qing Song LIN ; Chuan WANG
Chinese Journal of Hematology 2018;39(12):1021-1025
Objective: To analyze the hints role of surveillance cultures of Carbapenem-resistant Enterobacteriaceae (CRE) by perianal swabs in patients with hematological diseases, and seek risk factors of CRE bloodstream infection. Methods: The resistance of CRE from 2 914 patients with hematological diseases who cultured perianal swabs, CRE bloodstream infection and risk factors were analyzed during January 2016 to December 2017. Results: In this study, perianal swabs from 2 914 patients with hematological diseases were cultured, 74 patients were CRE positive, and bloodstream infection with CRE was found in 13 of these patients. A total of 87 CRE strains were isolated (The same patient only keep the first one for the same location), including 31 Klebsiella pheuminiae, 43 Escherichia coli, 8 Enterobacter cloacae and 6 other Enterobacteriaceae. The resistance rates to piperacillin / tazobactam, imipenem, meropenam, amikacin, levofloxacin, tigecycline were 91.9%, 74.4%, 98.8%, 17.6%, 74.4% and 8.0%, respectively. Resistance to carbapenem, aminoglycoside, quinolones and tegacycline were highly consistent between two sites from 13 patients, whose both perianal swabs and blood were positive in CRE cultures. Febrile neutropenic time, digestive tract symptoms and perianal infection were independent risk factors for bloodstream infection in patients with perianal swabs positive results, the odds ratios (OR) were 1.10 (P=0.029), 1.13 (P=0.005) and 1.23 (P=0.016), respectively. Conclusion: Perianal swabs surveillance cultures of CRE can be hints for CRE bloodstream infection in patients with hematological diseases, and also can provide suggestions for antibiotics. Long time of febrile neutropenic, digestive tract symptoms and perianal infection can be the early warning for CRE bloodstream infections.
Anti-Bacterial Agents
;
Bacteremia
;
Carbapenem-Resistant Enterobacteriaceae
;
Carbapenems
;
Enterobacteriaceae Infections
;
Hematologic Diseases
;
Humans
8.Clinical features and laboratory data analysis of Aeromonas bacteremia with hematological diseases.
Chun Hui XU ; Qing Song LIN ; Yan Xia LYU ; Guo Qing ZHU ; Zhi Ying TIAN ; Chao WANG ; Fu Jun SUN ; Hong Jing YAO ; Chuan WANG
Chinese Journal of Hematology 2019;40(12):1035-1039
Objective: To investigate the clinical and laboratory features of Aeromonas bacteremia in patients with hematological diseases, and provide evidence for the prevention and treatment of Aeromonas infection. Methods: A retrospective study of patients with bloodstream infection of Aeromonas in our hospital from January 2014 to December 2018 was carried out. The clinical characteristics, antimicrobial susceptibility, infection seasons, antimicrobial therapy and evolution were analyzed. Results: A total of 42 patients with hematological diseases had Aeromonas bloodstream infection within 5 years. Among them, 39 cases (92.9%) of bloodstream infection occurred in the stage of neutropenia. The median time of fever was 4 (1-27) d, 22 (52.4%) patients only had fever, 6 (14.3%) with gastrointestinal symptoms (abdominal pain, diarrhea, nausea, upper gastrointestinal bleeding) , 8 (19.0%) with pulmonary infection, 13 (31.0%) with skin and soft tissue infections. Seven patients (16.7%) died with skin and soft tissue infection. The resistance of Aeromonas to carbapenems was 68.3%-70.7%, while the resistance rate to cephalosporins, quinolones and aminoglycosides were less than 10%. Conclusions: Aeromonas bacteremia in patients with hematological diseases mainly occur in the neutropenia stage, usually with symptom like fever. The mortality is increased when accompanied by skin and soft tissue infection. Antibiotic use should be based on susceptibility results, and avoid the use of carbapenems.
Aeromonas
;
Anti-Bacterial Agents
;
Bacteremia
;
Data Analysis
;
Hematologic Diseases
;
Humans
;
Retrospective Studies
9.Clinical Analysis of 164 Children of Blood Disease Complicated with Invasive Fungal Disease.
Xiong-Yu LIAO ; Kun-Yin QIU ; Ruo-Hao WU ; Shu-Yi GUO ; Jian WANG ; Ke HUANG ; Hong-Gui XU ; Yang LI ; Jian-Pei FANG ; Dun-Hua ZHOU
Journal of Experimental Hematology 2019;27(5):1672-1677
OBJECTIVE:
To investigate the clinical characteristics, prevention and treatment of invasive fungal disease (IFD).
METHODS:
The clinical data of 164 patients who met the diagnostic criteria of IFD in our center from January 2012 to January 2015 were retrospectively analyzed. The incidence, clinical characteristics, related factors, treatment methods and prognosis were analyzed.
RESULTS:
Among 1289 cases of blood diseases, 164 cases suffered from IFD with inciduce of 12.7%. The main infection sites were as followed: lung, blood and gastrointestinal tract, with incidence of 84.2%, 5.5% and 3% respectively. The funge was found in 35 cases by detection; among fungi, the detected rate of candida albicans. aspergillus and candida glabrata was more high with 51.5%, 20% and 14.3% respectively. Among 164 childen with blood deseases complicated by IFD, 36 cases gained complete remission, 97 cases gained partial remission, 10 cases were stable, 11 cases were progressive and 10 cases died, the overall effective rate reached 81.1%. The univariate analysis showed that the gramulopenia, granulocyte recovery, long-term use of corticosteroid and immuno-suppressive agents, as well as different grades of diagnosis were significant factors affecting the efficacy of antifungal therapy for blood disease children with IFD, the multivariate analysis further showed that the granulocyte recovery and diagnosis grades were independent prognostic factors affecting the therapeutic efficacy for IFD children. The overall survival rate of IFD children with 12 weeks of antifungal treatnment was 81.7%, out of which the survival rate of IFD children at 12 weeks of treatment with itraconazole, voriconazole, amphotericin B and caspofungin was 81.4%, 80%, 69.4% and 97.1% respectively, there were significant differences in survival rate between each other by long rank test. In addition of caspofungin, the other 3 kinds of drugs had toxic side effects of different degrees, but IFD children could tolerated these effects after symptomatic treatment.
CONCLUSION
The incidence of IFD in children with blood deseases in our hospital is 12.7%, the lung is most common infective site, moreover patogens of IFD mainly is candida. The promotion of granulocyte recovery and early stratified diagnosis can contribule to the treatment of IFD. For the IFD children with better economic condition, the caspofungin is a potent antifungal agent with high efficacy, low toxicity and better prognosis.
Amphotericin B
;
Antifungal Agents
;
Child
;
Hematologic Diseases
;
etiology
;
Humans
;
Invasive Fungal Infections
;
complications
;
Retrospective Studies
10.Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies.
Hyeon Jeong SUH ; Inho KIM ; Joo Youn CHO ; Sang In PARK ; Seo Hyun YOON ; Jeong Ok LEE ; Youngil KOH ; Kyoung Ho SONG ; Pyoeng Gyun CHOE ; Kyung Sang YU ; Eu Suk KIM ; Hong Bin KIM ; Soo Mee BANG ; Nam Joong KIM ; Sang Hoon SONG ; Wan Beom PARK ; Myoung Don OH
Infection and Chemotherapy 2017;49(2):135-139
The posaconazole tablet formulation was developed to have improved bioavailability compared to the oral suspension. Here, we compared posaconazole plasma concentration (PPC) with the posaconazole oral suspension versus the tablet in Korean patients undergoing remission induction chemotherapy for hematologic malignancies. PPC was measured at 3, 8, and 15 days of treatment with the oral suspension (174 patients) or the tablet (40 patients). At all time-points, mean PPC was significantly higher with the tablet compared to the oral suspension. Our findings suggest that posaconazole tablets generate an optimal PPC earlier and in more patients than the oral suspension among Korean patients.
Antifungal Agents
;
Biological Availability
;
Dosage Forms
;
Drug Therapy
;
Hematologic Neoplasms*
;
Humans
;
Plasma*
;
Remission Induction
;
Tablets